Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Miracle Numb Spray** is a topical, fixed-dose local-anesthetic spray marketed by Tattoo Numbing Cream for temporary reduction of pain during tattoo procedures, including mid-session application to tattooed skin. The company lists **lidocaine 5%**, **prilocaine 4%**, and **epinephrine 1%** as active ingredients. Lidocaine and prilocaine reversibly inhibit voltage-gated sodium channels in peripheral sensory nerves, limiting nociceptive signal conduction; epinephrine produces local vasoconstriction that may reduce local blood flow and prolong the anesthetic effect. ([tattoonumbingcream.com](https://www.tattoonumbingcream.com/en-au/pages/ingredients))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Miracle Numb Spray.